Session by Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser – Geneva

In this video:
Session: Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser – Geneva
Topic: Automation and AI for Formulations Development

Key Highlights:
● AI is the simulation of human intelligence by machines to solve problems and to act rationally, like humans. It comprises 3 distinct types: human-created algorithms, machine learning and deep learning
● Digitisation and automation will transform quality control work in labs and on shop floors by introducing new ways of working
● Adoption of AI in the pharma industry is required due to increased costs, lower revenues, delayed launches and product recalls. Companies are looking for innovative solutions to combat these
● More efficient and automated processes, data-driven decisions and better predictive analytics tools are needed to increase R&D success and develop new drugs
● In FDD, AI can be used for clinical trial design and monitoring, QA and QC, pharmaceutical manufacturing, pharmaceutical product management, drug discovery and pharmaceutical product development